STAGE IIC COLON CANCER AJCC V8
Clinical trials for STAGE IIC COLON CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIC COLON CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIC COLON CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to stop BRAF colon cancer in its tracks
Disease control OngoingThis study tests whether adding two targeted drugs (encorafenib and cetuximab) after standard surgery and chemotherapy can lower the chance of cancer coming back in people with a specific genetic type of stage II/III colon cancer (BRAF V600E). Participants either receive the drug…
Matched conditions: STAGE IIC COLON CANCER AJCC V8
Phase: PHASE2, PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 17, 2026 11:36 UTC
-
The hidden cost of beating cancer: new study tracks financial toll on patients
Knowledge-focused OngoingThis study follows 565 people with stage I-III colon or rectal cancer who are being treated with the goal of a cure. Researchers track how treatment affects patients' finances and quality of life over 12 months. The goal is to help doctors understand the financial burden of cance…
Matched conditions: STAGE IIC COLON CANCER AJCC V8
Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Knowledge-focused
Last updated May 17, 2026 11:37 UTC